1.
Usta CS, Atik TK, Ozcaglayan R, Bulbul CB, Camili FE, Adali E. Does the fibrinogen/albumin ratio predict the prognosis of pregnancies with abortus imminens? Saudi Med J. 2021;42(3):255-263. doi:10.15537/smj. 2021.42.3.20200695
2.
Balikoğlu M, Bayraktar B, Arici Yurtkul A, Özeren M. The effect of vaginal bleeding in early pregnancy on first trimester screening test, uterine artery doppler indices and perinatal outcomes. Med Rec. 2023; 5(2):393-399. doi:10.37990/medr.1196046
3.
Katar-Yildirim C, Tokmak A, Yildirim C, Erel O, Caglar AT. Investigation of serum thiol/disulphide homeostasis in patients with abortus imminens. J Matern-Fetal Neonatal Med Off J Eur Assoc Perinat Med Fed Asia Ocean Perinat Soc Int Soc Perinat Obstet. 2018;31(18):2457-2462. doi:10.1080/14767058.2017.1344962
4.
Weiss JL, Malone FD, Vidaver J, et al. Threatened abortion: a risk factor for poor pregnancy outcome, a population-based screening study. Am J Obstet Gynecol. 2004;190(3):745-750. doi:10.1016/j.ajog.2003.09.023
5.
Zhao Y, D’Souza R, Gao Y, et al. Progestogens in women with threatened miscarriage or recurrent miscarriage: a meta-analysis. Acta Obstet Gynecol Scand. 2024;103(9):1689-1701. doi:10.1111/aogs.14829
6.
Hanna LM, Habashi LN, Topouzada ST, El Shebini SM, Galal OM. Nutritional status and unfavourable pregnancy outcome in Egyptian women. Nutr Rep Int. 1989;39(6):1217-1226.
7.
Tommaselli GA, Di Spiezio Sardo A, Di Carlo C, et al. Do serum leptin levels have a role in the prediction of pregnancy outcome in case of threatened miscarriage? Clin Endocrinol (Oxf). 2006;65(6):772-775. doi: 10.1111/j.1365-2265.2006.02665.x
8.
Çendek BD, Bayraktar B, Körpe B, Üstün YE, Keski NL, Erel Ö. Ischemia-modified albumin levels in threatened abortion and missed abortion compared to healthy pregnancies. J Exp Clin Med. 2024;41(1):102-107.
9.
Hakeem LA, Bello YO, Obajimi GO, et al. Inflammatory cytokines in maternal serum between women with threatened miscarriage and normal pregnancy. Int J Gynaecol Obstet Off Organ Int Fed Gynaecol Obstet. 2024;164(1):255-261. doi:10.1002/ijgo.15009
10.
Isenlik BS, Sarica MC, Kaygun BC, Inal HA. An evaluation of serum blood parameters and amyloid a levels in pregnant women with threatened miscarriage. Am J Reprod Immunol N Y N 1989. 2024;91(3): e13829. doi:10.1111/aji.13829
11.
Calleja-Agius J, Schembri-Wismayer P, Calleja N, Brincat M, Spiteri D. Obstetric outcome and cytokine levels in threatened miscarriage. Gynecol Endocrinol Off J Int Soc Gynecol Endocrinol. 2011;27(2):121-127. doi:10.3109/09513590.2010.487614
12.
Chen XL, Xue L, Wang W, et al. Prognostic significance of the combination of preoperative hemoglobin, albumin, lymphocyte and platelet in patients with gastric carcinoma: a retrospective cohort study. Oncotarget. 2015;6(38):41370. doi:10.18632/oncotarget.5629
13.
Farag CM, Antar R, Akosman S, Ng M, Whalen MJ. What is hemoglobin, albumin, lymphocyte, platelet (HALP) score? A comprehensive literature review of HALP’s prognostic ability in different cancer types. Oncotarget. 2023;14:153-172. doi:10.18632/oncotarget.28367
14.
Alshuweishi Y, Basudan AM, Alfaifi M, Daghistani H, Alfhili MA. Association of the HALP score with dyslipidemia: a large, nationwide retrospective study. Med Kaunas Lith. 2023;59(11):2002. doi:10.3390/medicina59112002
15.
Xu H, Zheng X, Ai J, Yang L. Hemoglobin, albumin, lymphocyte, and platelet (HALP) score and cancer prognosis: a systematic review and meta-analysis of 13,110 patients. Int Immunopharmacol. 2023;114: 109496. doi:10.1016/j.intimp.2022.109496
16.
Ekinci F, Balcik OY, Oktay E, Erdogan AP. HALP score as a new prognostic index in metastatic renal cell cancer. J Coll Physicians Surg--Pak JCPSP. 2022;32(3):313-318. doi:10.29271/jcpsp.2022.03.313
17.
Acar O, Ayhan M, Demir B, Ekinci F, Aytac A, Erdogan AP. HALP score as a new prognostic factor for patients with metastatic bladder cancer. J Coll Physicians Surg--Pak JCPSP. 2023;33(12):1405-1409. doi:10.29271/jcpsp.2023.12.1405
18.
Sargin ZG, Dusunceli I. The effect of HALP score on the prognosis of gastric adenocarcinoma. J Coll Physicians Surg--Pak JCPSP. 2022;32(9): 1154-1159. doi:10.29271/jcpsp.2022.09.1154
19.
Rodgers SK, Chang C, DeBardeleben JT, Horrow MM. Normal and abnormal US findings in early first-trimester pregnancy: review of the society of radiologists in ultrasound 2012 consensus panel recommendations. Radiogr Rev Publ Radiol Soc N Am Inc. 2015;35(7): 2135-2148. doi:10.1148/rg.2015150092
20.
Soysal C, Sarı H, Işıkalan MM, et al. Role of the systemic immune-inflammation index in threatened abortion patients and predicting of abortion. J Obstet Gynaecol Res. 2023;49(7):1723-1728. doi:10.1111/jog. 15655
21.
Biyik I, Albayrak M, Keskin F. Platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in missed abortion. Rev Bras Ginecol E Obstet Rev Fed Bras Soc Ginecol E Obstet. 2020;42(5):235-239. doi:10.1055/s-0040-1709693
22.
Vecchié A, Bonaventura A, Carbone F, et al. Antiapolipoprotein A-1 autoantibody positivity is associated with threatened abortion. BioMed Res Int. 2020;2020:9309121. doi:10.1155/2020/9309121
23.
Mate A, Reyes-Goya C, Santana-Garrido Á, Vázquez CM. Lifestyle, maternal nutrition and healthy pregnancy. Curr Vasc Pharmacol. 2021; 19(2):132-140. doi:10.2174/1570161118666200401112955
24.
Oñate-Ocaña LF, Aiello-Crocifoglio V, Gallardo-Rincón D, et al. Serum albumin as a significant prognostic factor for patients with gastric carcinoma. Ann Surg Oncol. 2007;14(2):381-389. doi:10.1245/s10434-006-9093-x
25.
Caro JJ, Salas M, Ward A, Goss G. Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review. Cancer. 2001;91(12):2214-2221. doi.org/10.1002/1097-0142(20010615)91: 12<2214::AID-CNCR1251>3.0.CO;2-P
26.
Soykan Sert Z, Bertizlioğlu M. Predictive value of the HALP score for pre-eclampsia with severe features. Postgrad Med. 2024;136(4):468-473. doi:10.1080/00325481.2024.2359892
27.
Hasan R, Baird DD, Herring AH, Olshan AF, Jonsson Funk ML, Hartmann KE. Association between first-trimester vaginal bleeding and miscarriage. Obstet Gynecol. 2009;114(4):860-867. doi:10.1097/AOG.0b013e3181b79796
28.
Basama FMS, Crosfill F. The outcome of pregnancies in 182 women with threatened miscarriage. Arch Gynecol Obstet. 2004;270(2):86-90. doi:10. 1007/s00404-003-0475-z
29.
Saraswat L, Bhattacharya S, Maheshwari A, Bhattacharya S. Maternal and perinatal outcome in women with threatened miscarriage in the first trimester: a systematic review. BJOG Int J Obstet Gynaecol. 2010; 117(3):245-257. doi:10.1111/j.1471-0528.2009.02427.x
30.
Ozdemirci S, Karahanoglu E, Esinler D, Gelisen O, Kayıkcıoglu F. Influence of threatened miscarriage on pregnancy and early postpartum period: a case-control report. J Matern-Fetal Neonatal Med Off J Eur Assoc Perinat Med Fed Asia Ocean Perinat Soc Int Soc Perinat Obstet. 2015;28(10):1186-1189. doi:10.3109/14767058.2014.947577